BAH · Booz Allen Hamilton Holding Corporation — research history

Stage crashed before producing an artifact (e.g. LM Studio timeout, malformed JSON, network error). The cooldown will hold this off the queue for ~1h before retry.

Score falls well below the publication threshold (25/100) due to absent smart-money support, muted technicals, and elevated leverage (2.9x net debt/EBITDA) in a declining-revenue environment. Anti-signal gates for customer concentration and dilution also remain unresolved, warranting a skip.

Booz Allen Hamilton is a federal defense/intelligence consulting and advanced technology firm trading at 11.5x forward earnings — near the bottom of its historical range after a ~35% drawdown from 52-week highs driven by Civil-sector spending headwinds (DOGE-era budget cuts). Q4 FY26 EPS crushed estimates by +33%, with margin expansion to 18%+ on cost discipline. The defense and intelligence portfolio is stable; AI/cyber productization is a genuine growth vector. No open-market insider buys in the past 90 days — all recent Form 4s were RSU grants (code A). Options flow is mixed (put/call ratio 1.87) with no whale positioning. Near-term catalyst: July 24 earnings with FY27 guidance as the next re-rating opportunity.

Absence of insider buying, elevated leverage (3.1x net debt/EBITDA), and concentrated revenue streams outweigh the apparent valuation discount; bearish options flow and lack of near-term catalysts justify a skip.

BAH just reported fiscal Q4 2026 earnings on May 22, beating EPS consensus by +33% ($1.78 actual vs $1.34 estimate) while revenue missed slightly (-3.4% YoY). The stock has been decimated over the past year — down ~40% from its $120.05 52-week high to $77.49 on federal spending uncertainty tied to DOGE and civil government headcount reduction. Forward P/E of 12.4x vs sector medians of 18-20x is a notable discount, but that discount reflects real revenue pressure: FY2026 revenue guidance missed consensus by -0.7%. No insider open-market purchases found in the past 90 days — all recent Form 4s were RSU vesting events (not discretionary buys). Options flow shows a put/call ratio of 3.0 and net bearish dollar bias, reflecting elevated market fear about the federal spending environment. MACD just printed a bullish cross two bars ago; RSI neutral at 53. No compelling mispricing narrative given secular headwinds to civil business revenue.

Deteriorating fundamentals (revenue down 10%, margin compression, 3.95x leverage) combined with zero insider conviction and active concentration/dilution anti-signals render this dossier uninvestable. Elevated IV does not compensate for the lack of a stabilizing catalyst or quality floor to support an income structure.

BAH is a federal IT/consulting firm deeply embedded in defense, intelligence, and civil agencies. The stock has declined ~31% YTD from ~$110 to $75, approaching its 52-week low of $74.26 set in late February 2026 — representing meaningful mean reversion. However, the decline is fundamentally driven: revenue fell ~10% YoY ($8.4B LTM vs $9.0B prior year), civil agency work dropped sharply (35%→28% of mix), and G&A expanded as a percent of revenue despite lower top line. No insider open-market purchases in 90 days; all recent Form 4s show F-codes (forfeitures) or tax-related sales, not directional conviction. The Q3 FY2026 EPS beat (+37%) was largely driven by a $57M discrete tax benefit — not operational. New CFO Troy Lahr appointment is notable but too fresh to signal direction. The stock offers a compelling FCF yield (~8-9%), modest forward P/E (12x), and elevated IV ahead of May 22 earnings — supporting an income thesis rather than an asymmetric long.